Similar results were observed when we replaced diabetes with inflammatory markers (i.e., C-reactive protein [CRP], tumor necrosis factor alpha [TNF-α], interleukin-6 [IL-6], and monocyte chemoattractant protein-1 [MCP-1]) or serum albumin concentration. This evidence concerns the gene IL6 and diabetes mellitus.